To further explore the clinical relevance of RFNG pS255‐regulated p53 phosphorylation, as well as CDKN1A and SLC7A11 protein levels, we collected samples from CRC patients with p53 WT receiving oxaliplatin‐based chemotherapy. The gene discussed is CDKN1A; the disease is colorectal carcinoma.